QUOTE AND NEWS
OilVoice  Sep 19  Comment 
Andes AIM AEN BCBA AEN the Latin American EP group announces its unaudited interim results for the six month period ending 30 June 2016. Operational Review Period highlights 6 increase in a
OilVoice  Aug 25  Comment 
The Board of Andes AIM AEN BCBA AEN the producer and explorer in Argentina and Colombia is pleased to provide an update on current exploration operations in the Chachahuen block in the Province
OilVoice  Aug 1  Comment 
The Board of Andes AIM AEN BCBA AEN is pleased to provide an update on current production at a Group level based on the June 2016 sales and production reports. Group production for June 2016 was
OilVoice  May 13  Comment 
The Board of Andes AIM AEN BCBA AEN is pleased to provide an update on current production at a Group level based on the April and March 2016 sales and production reports. Group production for Ap
OilVoice  Apr 22  Comment 
The Board of Andes AIM AEN BCBA AEN is pleased to provide an update on current production at a Group level based on the February 2016 sales and production reports. Group production for February
OilVoice  Mar 9  Comment 
The Board of Andes AIM AEN BCBA AEN is pleased to provide an update on current production at a Group level based on the January 2016 sales and production reports. Group production for January 20
OilVoice  Feb 3  Comment 
Further to the operational update on the Chachahuen licence issued on 25 January the Board of Andes AIM AEN BCBA AEN is pleased to provide an update on current production at a Group level based
OilVoice  Jan 25  Comment 
The Board of Andes AIM AEN BCBA AEN the producer and explorer in Argentina and Colombia is pleased to provide an update on current production development and exploration operations in the Chac
OilVoice  Mar 9  Comment 
The Board of Andes AIM AEN BCBA AEN is pleased to announce the results of a multi stage fracture and production test on the Las Varillas x1 well which was drilled in the first half of 2014 an
OilVoice  Feb 19  Comment 
Operational Update The Board of Andes AIM AEN BCBA AEN is pleased to provide an update on the Companys operating performance. Several activities have been carried out over recent months in orde





 
Adeona Pharmaceuticals, Inc. (Adeona) is a development-stage pharmaceutical company developing medicines for central nervous systems diseases. Trimesta (estriol) is an investigational oral drug for the treatment of relapsingremitting multiple sclerosis. ZinthioneinTM ZC (zinc cysteine) is an oral, gastro-retentive, sustained-release medical food candidate being developed for the dietary management of Alzheimer’s disease and mild cognitive impairment. In December of 2009, Adeona initiated a 60-patient clinical study. Effirma (flupirtine) is an investigational oral drug for the treatment of fibromyalgia syndrome. dnaJP1 (hsp peptide) is an investigational oral drug for the treatment of rheumatoid arthritis. CD4 Inhibitor 802-2 (cyclic heptapeptide) is an investigational drug for the prevention of severe graft-versus-host disease. On July 10, 2009 the Company acquired Hart Lab, LLC.



References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki